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Emotional responses, such as fear and anxiety, are fundamentally
important behavioral phenomena with strong fitness components
in most animal species. Anxiety-related disorders continue to
represent a major unmet medical need in our society, mostly
because we still do not fully understand the mechanisms of these
diseases. Animal models may speed up discovery of these mecha-
nisms. The zebrafish is a highly promising model organism in this
field. Here, we report the identification of a chemokine-like gene
family, samdori (sam), and present functional characterization of
one of its members, sam2. We show exclusive mRNA expression
of sam2 in the CNS, predominantly in the dorsal habenula, telen-
cephalon, and hypothalamus. We found knockout (KO) zebrafish to
exhibit altered anxiety-related responses in the tank, scototaxis and
shoaling assays, and increased crh mRNA expression in their hypo-
thalamus compared with wild-type fish. To investigate generaliz-
ability of our findings to mammals, we developed a Sam2 KO
mouse and compared it to wild-type littermates. Consistent with
zebrafish findings, homozygous KOmice exhibited signs of elevated
anxiety. We also found bath application of purified SAM2 protein to
increase inhibitory postsynaptic transmission onto CRH neurons of
the paraventricular nucleus. Finally, we identified a human homolog
of SAM2, and were able to refine a candidate gene region encom-
passing SAM2, among 21 annotated genes, which is associated with
intellectual disability and autism spectrum disorder in the 12q14.1
deletion syndrome. Taken together, these results suggest a crucial
and evolutionarily conserved role of sam2 in regulating mechanisms
associated with anxiety.
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Emotional responses, such as fear (responses to the appear-ance of well-defined and clearly present aversive stimuli) and
anxiety (responses seen under aversive contexts in which the
clear presence of fear inducing stimuli cannot be ascertained or
these stimuli are continuously present and diffuse), are essential
behavioral phenomena that have strong fitness components in all
species (1). Anxiety-related disorders continue to represent a
major unmet medical need in our society. Despite concerted
efforts to develop anxiolytic and antidepressant pharmacother-
apies, a large proportion of patients remain unresponsive to
medication (2). This is due to the fact that we still do not fully
understand the mechanisms of these diseases. To facilitate
mechanistic analysis and to speed up the process of target
identification and psychopharmacological characterization of
compounds, animal models have been proposed.
Emotional responses, such as fear and anxiety, are regulated
by various neuromodulators (3). Recently, studies have raised
the possibility that chemokines may also possess neuromodulatory
functions. Chemokines are small, secreted signaling proteins that
commonly act as chemo-attractants to guide the migration of cells
of the immune system. Importantly, chemokines are also expressed
in neurons and glial cells of the central nervous system (CNS);
while their role in the brain has mainly been associated with
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neuro-inflammatory responses, it is becoming more evident that
chemokines in the brain may hold other functions (4–6).
Emotion dysregulation can lead to serious behavioral prob-
lems and impaired social interaction associated with a variety of
disease conditions, including attention deficit hyperactivity dis-
order, bipolar disorder, and posttraumatic stress disorder (7, 8).
Despite the paucity of proper treatment options for such disor-
ders, the exploration of possible underlying genetic and bi-
ological mechanisms has been slow. The identification of novel
genes associated with emotional behavior and understanding
neural mechanisms of higher brain function remains a major goal
of biology.
The use of animal models has greatly aided this research. The
zebrafish (Danio rerio) has emerged as a promising model or-
ganism for the study of complex neuropsychiatric diseases be-
cause of the well-defined behavioral phenotypes of this species
(9), and because of its evolutionarily conserved brain structures
and functions. One example of such a brain structure is the
habenula (Hb), which is connected with the subpallium and hy-
pothalamus, and is implicated in fear, anxiety, addiction, and
mood disorders (10, 11).
The zebrafish is useful for large-scale forward genetic screens
to discover novel genes involved in CNS development, an ap-
proach we have utilized (12, 13). Over 10 y ago we discovered a
chemokine-like gene family, called samdori (sam), using genetic
screens (i.e., insertional mutagenesis with a unique dual re-
porter system) (SI Appendix, Fig. S1). We present herein the
body of work that has extended from initial gene discovery and
encompasses various analyses of the physiological functions of
this family.
A member of this family, sam2 exhibits exclusive brain-specific
expression, predominantly in neurons of the dorsal Hb (dHb), as
well as the telencephalic area and hypothalamus. Here, we re-
port the development of a zebrafish null mutant (KO) in which
this gene is silenced. We investigate the effect of this null mu-
tation using behavioral assays developed to induce and measure
fear and anxiety responses. To investigate the generalizability of
our findings obtained with zebrafish, we also report herein the
development and analysis of a mouse null mutant in which the
mammalian homolog of the zebrafish sam2 gene is silenced. We
found phenotypical alterations in the Sam2 KO mice that are
consistent with those we observed in the zebrafish null mutants,
suggesting that Sam2 is critical for regulating anxiety across such
evolutionarily distant species as mammals and fish.
In addition, we also analyzed a variety of markers in the zebrafish
sam2 KO (colocalization studies), which uncovered changes in
mRNA expression of the gene encoding corticotropin-releasing
hormone (CRH), a hormone involved in stress and anxiety
responses in mammals (14). We followed up this investigation
with whole-cell patch-clamp electrophysiological recordings
from CRH neurons in the mouse hypothalamus, and found
that Sam2 modulated GABAergic synaptic transmission on
CRH neurons.
Finally, we investigated whether mutations in the human ge-
nome potentially affecting SAM2 function may have functional,
behavioral consequences. We identified patients with micro-
deletions/microduplications in 12q14.1, including SAM2, who
suffered from a variety of behavioral and intellectual problems.
Using six copy-number variations (CNVs), we were able to refine
the candidate gene region encompassing SAM2 among 21 anno-
tated genes at 12q14.1.
In summary, we describe the discovery of a chemokine-like
protein family and provide initial functional characterization of
one of its members, sam2. Taken together, our multidisciplinary
results demonstrate a potentially crucial role of this candidate
gene in the regulation of emotion-related behaviors across evo-
lutionarily distant species, and delineate a target that may allow
the development of effective pharmacotherapy for human CNS
disorders associated with altered fear, anxiety, and stress.
Results
Identification of samdori2. Using insertional mutagenesis to iden-
tify novel functional genes, we isolated a chemokine-like gene,
sam [also called TAFA (15) and FAM19A in the National Center
for Biotechnology Information database] (SI Appendix, Fig. S1).
Subsequently, we also isolated other members of sam family
based upon the sequences in the database. We have identified
eight members in the zebrafish sam gene family, and found them
highly conserved in mouse and human at the amino acid se-
quence level (SI Appendix, Fig. S2 A–E). All Sam proteins
exhibited 10 regularly spaced cysteine residues with a pattern of
CX7CCX13CXCX14CX11CX4CX5CX10C, a sequence similar to
that of CC-type chemokines (15).
Using whole-mount in situ hybridization in zebrafish, we
found all sam genes to be exclusively expressed in the CNS at
larval stages (SI Appendix, Fig. S2 F–O). Among them, we fo-
cused on the functional analysis of the sam2 gene, because we
found sam2 to be predominantly expressed in the dHb of adult
fish (Fig. 1). To further characterize sam2-expressing cells, we
performed whole-mount in situ hybridization in larval and adult
fish brains using various neuronal markers. In addition to dHb,
sam2-expressing cells were also detected in the telencephalon
and otic neurons in larvae (SI Appendix, Fig. S3A). In situ hy-
bridization of adult brain and serial sectioning revealed the
detailed expressions of sam2 in the medial zone of the dorsal
telencephalic area (Dm), the dorsal nucleus of the ventral tel-
encephalon (Vd), preoptic area of hypothalamus (PPa), and
other hypothalamic regions (ATN, anterior tuberal nucleus;
Hc, caudal zone of periventricular hypothalamus; Hd, dorsal
zone of periventricular hypothalamus; and PTN, posterior
tuberal nucleus) (Fig. 1 and SI Appendix, Fig. S3 and Table S1).
To assess the distribution of sam2 within excitatory and in-
hibitory circuits, we performed double in situ hybridization with
GABAergic markers (16, 17) and glutamatergic markers (16,
17). We found sam2+ cells in GAD67/gad1b-expressing cells in
the Vd, central nucleus of the ventral region (Vc), and PPa
(Fig. 1D and SI Appendix, Fig. S4). In the diencephalon, sam2-
expressing cells were observed adjacent to GAD65/gad2+ cells
in the hypothalamic area, such as the ATN and PTN, and
periventricular hypothalamus (SI Appendix, Fig. S4). With the
glutamatergic markers, sam2 mRNA was partially overlapped
with vglut2b in the Dm but not in other forebrain regions (Fig. 1
B and C). In addition, sam2 was found to overlap with vglut2a
in the dorsal region of the Hb (Fig. 1F). Expression of sam2 in
the Hb was further examined by costaining with dHb-specific
kctd12.1 (lov) (18, 19) or ventral Hb (vHb)-specific marker,
aoc1 or dHb/vHb marker fam84b (20) (SI Appendix, Fig. S5 A–
E). sam2 expression was found not to colocalize with known
markers of dopaminergic (21), oxytocinergic (22), or hypo-
cretinergic (23) neurons (Fig. 1 and SI Appendix, Fig. S5 F–H′).
The Hb has been implicated in the regulation of emotion, in-
cluding anxiety, fear, depression, and reward (7, 24). The fish
telencephalic regions are homologous to the mammalian
amygdala (Dm) and striatum (Vd), structures that are known
to play fundamental roles in emotion-related behaviors in
mammals (25). Thus, expression of the sam2 gene detected in
the dHb, telencephalic areas (Dm, Vd), and hypothalamic
regions prompted us to investigate its function in the regula-
tion of emotion.
Normal Development of Neuronal Cells in sam2 KO Fish. To in-
vestigate the function of sam2, we created two sam2 KO zebra-
fish lines, taking advantage of targeted mutagenesis utilizing
zinc-finger nucleases (ZFNs) (26, 27). The 5-bp deletion
(sam2cnu1) and 17-bp deletion (sam2cnu2) of the two alleles induced
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frame-shift mutations (Fig. 2 A–B′), which lead to alteration of
the protein-coding sequence (SI Appendix, Fig. S6A). Both sam2
KO lines showed normal morphology during embryonic devel-
opment (Fig. 2 C and C′), survived to adulthood, and were fer-
tile. To test whether sam2 is necessary for the development of
specific neuronal cell-types, we examined the expression of
various molecular markers in sam2 KO zebrafish (SI Appendix,
Fig. S6 B–G′). Compared with wild-type fish, we could not
detect any significant differences in the expression patterns of
dopaminergic neuronal markers [tyrosine hydroxylase (th) (21),
dopamine transporter (dat) (28), and nuclear receptor related
1 protein (nurr-1) (28)], serotonergic neuronal markers [tryp-
tophan hydroxylase raphe (tphR) and 5-hydroxytryptophan (5-
HT)] (29), oxytocinergic neuronal marker oxytocin (oxt) (22),
and interpeduncular nucleus (IPN) marker somatostatin1.1
(sst1.1) (30). Moreover, sam2 KO embryos showed normal ex-
pression of neurohormonal genes (SI Appendix, Fig. S6 H–M′),
including hypocretin/orexin (hcrt) (23), melanin concentrating
hormone (mch) (31), agouti related protein homolog (agrp) (32),
neuropeptide Y (npy) (33), and pet-1 (fev; ETS oncogene family)
(29). In addition, we observed normal hypothalamus–locus
coeruleus projections in progenies of the Tg(hcrt:mEGFP) (23)
transgenic line crossed to the sam2cnu1 mutant (SI Appendix, Fig.
S6 N–O′). Moreover, the targeting of Hb efferent axons in-
nervating the IPN appeared to be largely unaffected in the
Et(-1.0otpa:mmGFP)hd1 (34) transgenic embryos crossed to
sam2cnu1 KO fish (Fig. 2 D and E′). Therefore, we conclude
that sam2 is not directly involved in the generation, migration,
and axonal growth of neurons.
Increase of Anxiety-Like Responses in sam2 Mutant Fish. We next
examined whether the loss of sam2 affects behaviors associated
with anxiety using the open (novel) tank (35, 36) and dark/light
preference (scototaxis) (37) tests. Anxiety and fear are related
phenomena, but can be distinguished. Responses induced by a
present and clearly detectable aversive stimulus are regarded as
fear responses (behavior aimed at the avoidance of the stimulus),
whereas anxiety-like behavior is found under diffuse aversive
conditions: that is, without the appearance or clear presence of
such stimuli. Novelty is an aversive context without the presence
of specific fear-inducing stimuli, and thus novel test situations
are often used to quantify anxiety. In the novel tank, when placed
individually, sam2cnu1 KO fish showed normal locomotor activity,
as indicated by no changes in total distance traveled (Fig. 3A)
(sam2+/+, 4,359.29 ± 218.68 cm, n = 18; sam2−/−, 4,088.71 ±
249.83 cm, n = 28) and in average velocity (Fig. 3B) (sam2+/+,
7.63 ± 0.37 cm/s, n = 18; sam2−/−, 7.02 ± 0.41 cm/s, n = 28),
compared with control sibling fish. Moreover, there were no
significant differences in the frequency of transition to the upper
half of the test tank between sam2cnu1 KO and control fish (Fig.
3C) (sam2+/+, 30 ± 6.93, n = 18; sam2−/−, 34.86 ± 4.19, n = 28), a
measure of vertical exploration. However, sam2cnu1 KO fish
exhibited behavioral characteristics indicative of elevated levels
of anxiety, including an increased number of erratic movements
(1, 38) (Fig. 3D) (sam2+/+, 52.67 ± 9.19, n = 18; sam2−/−,
142.14 ± 12.50, n = 28) and number of freezing events (35, 36)
(Fig. 3E) (sam2+/+, 0.17 ± 0.09, n = 18; sam2−/−, 0.44 ± 0.10, n =
27). Freezing is a typical response seen in aversive contexts and
can be used to quantify the level of anxiety in a variety of species,
Fig. 1. Characterization of sam2-expressing cells in the adult zebrafish brain. (A and A′) Whole-mount two color in situ hybridization of a dissected zebrafish
brain with sam2 and a dopaminergic neuron marker, th. Anterior is to the left; lateral (A) and dorsal view (A′). The sam2 expression region did not overlap
with th+ neurons. Prominent sam2 expression is seen in the Vd and Hb as well as hypothalamic regions. (B–D) Section images of brain hybridized with sam2/
vglut2b (B, sagittal section; C, cross-section) or sam2/gad1b (D). (E and F) Cross-section of Hb region stained with sam2 alone (E) or sam2/vglut2a (F) probes.
AN, auditory nerve; D, area dorsalis telencephlali; Dc, central zone of area dorsalis telencephali; MO, medulla oblongata; OB, olfactory bulb; TeO, optic
tectum; Vv, ventral nucleus of area ventral telencephali. (Scale bars, 100 μm.)














including zebrafish and rodents (36). Erratic movement has also
been shown to be a characteristic sign of anxiety or fear in
zebrafish (36, 39). Thus, our results indicate that sam2 may be
involved in the regulation of anxiety-like responses in zebrafish.
To further investigate anxiety-like behavior in sam2cnu1 KO fish,
we also measured thigmotaxis (avoidance of open areas) in the
novel tank. Increased thigmotaxis in novel contexts has been
interpreted as a sign of anxiety (36). sam2cnu1 KO fish showed
higher preference for the corner over the center of the test tank
(SI Appendix, Fig. S7A) (sam2+/+ at the corner, 21.22 ± 0.56 s, at
the center 34.15 ± 0.70 s, n = 12; sam2−/− at the corner, 26.83 ±
0.95 s, at the center, 29.14 ± 0.89 s, n = 12). The light/dark
paradigm is another frequently employed test of fear and anxiety
in zebrafish and rodents (37), and zebrafish have been shown to
exhibit scototaxis (i.e., dark preference). Consistent with the
results obtained in the novel tank task, in the light/dark para-
digm, adult sam2cnu1 KO fish traveled a shorter distance (Fig.
3F) (sam2+/+, 1,533.59 ± 191.18 cm, n = 18; sam2−/−, 788.88 ±
116.09 cm, n = 24), spent less time in the white arena (SI Ap-
pendix, Fig. S7 B and C) (sam2+/+ in the black, 733.125 ± 80.66 s,
in the white 168.38 ± 80.42 s, n = 18; sam2−/− in the black,
811.5 ± 64.81 s, in the white 104.08 ± 87.67 s, n = 24), and
exhibited reduced frequency of black/white transitions compared
with wild-type (Fig. 3G) (sam2+/+, 81.67 ± 8.74, n = 18; sam2−/−,
38.69 ± 4.36, n = 24), alterations that further corroborate the
notion that the null mutant fish suffered from elevated levels of
anxiety. These results suggest that sam2 may regulate emotion-
related behaviors.
Increase of Social Cohesion in sam2 KO Fish. Zebrafish form groups,
a behavior called shoaling. One of the adaptive functions of this
social behavior has been shown to be predator-avoidance.
Measures of shoal cohesion have been successfully utilized in
the analysis and modeling of anxiety and fear in vertebrates,
including zebrafish (1, 36). To test whether sam2 KO fish exhibit
altered shoaling behavior, a group of five sam2 KO fish were
placed in a novel tank at a time and monitored by 3D video
tracking. We recorded the swim paths of the fish in the group for
30 min (Fig. 4 and SI Appendix, S8 A–B′) (40). Because wild-type
zebrafish typically take 10 min to habituate to a novel tank (41),
we analyzed the behavior of fish at two time points: early phase
(before habituation, 5–8 min) and late phase (after habituation,
13–16 min) of the session. During the early phase, both sam2 KO
and control fish showed typical anxiety-like responses by staying
close to the bottom of the tank. However, at the late phase
control sibling fish started to swim in the middle and the top
layers of the water (Fig. 4 A and B), a response interpreted as
reduction of anxiety. In sharp contrast, sam2 KO fish remained
near the bottom of the tank (Fig. 4 A′ and B′ and Movie S1),
suggesting impaired habituation to the novel environment (i.e.,
Fig. 2. Generation of sam2 KO fish using ZFNs. (A) DNA sequencing analysis of two sam2 KO alleles (sam2cnu1 and sam2cnu2) with 5-bp and 17-bp deletion,
respectively. Yellow mark, Left and Right ZFN-binding regions; red, spacer. (B and B′) Allele-specific genotyping of sam2cnu1 and sam2cnu2 KO fish by genomic
PCR and digestion for BtgI site (CCGTGG) newly created in sam2cnu1. (C and C′) Normal morphology of sam2cnu1 KO embryo at 3 d. (D–E′) Projections of Hb
efferent axons targeting the IPN in the Et(-1.0otpa:mmGFP)hd1 transgenic sam2cnu1 KO fish were not visibly affected. Lateral views (D and E) and dorsal views
(D′ and E′). dIPN, dorsal IPN; FR, fasciculus retroflexus; lFR, Left FR; lHb, Left Hb; MR, median raphe; rFR, Right FR; rHb, Right HbvIPN, ventral IPN. (Scale bar,
100 μm.)
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maintenance of elevated levels of anxiety) in sam2 KO fish. We
next examined social cohesion in sam2 KO zebrafish by mea-
suring the distance between a focal fish and each of its shoal
members (interindividual distance) (41–43). Control fish signif-
icantly increased their mean interindividual distance from the
early phase to the late phase, suggesting the reduction of novelty-
induced anxiety (Fig. 4 C and C′). However, sam2 KO fish did
not show such changes in mean individual distance, and main-
tained the same strong shoal cohesion (Fig. 4C′ and SI Appendix,
Fig. S8). The effect size (Cohen’s d) for cohesion of the control
and sam2cnu1 KO fish was d = −0.063 at the early phase (5–
8 min) and d = −0.80 at the late phase (13–16 min). These results
confirm that sam2 KO mutants exhibit elevated levels of anxiety
compared with wild-type fish.
Excessive Anxiety/Fear Behavior in sam2 KO Fish in Response to Alarm
Substance. The above behavioral paradigms are considered to
induce anxiety-like responses, because they do not use specific
clearly present aversive stimuli. To test fear responses, we con-
ducted another test in which an aversive stimulus was specifically
provided and was clearly present during the test. A clearly pre-
sent aversive stimulus that may be delivered in a well-defined
manner to the zebrafish is the alarm substance (38). Among
other behavioral responses, the alarm substance has been shown
to induce a reliable alteration in shoaling that may be used to
measure fear in zebrafish (38). In our study, we examined
changes in shoal cohesion in response to administration of the
alarm substance (SI Appendix, Fig. S9). Both control and sam2
KO fish exhibited increased shoal cohesion (reduced distance
among shoal members) in response to the delivery of alarm
substance. However, the relative decrease of interindividual
distance in sam2 KO fish was more robust compared with that of
wild-type control siblings. The effect size between before and
after alarm treatment was d = −1.09 for control and d =
−1.22 for sam2cnu1 KO fish, respectively. The effect size between
control and sam2cnu1 KO fish was d = −0.96 before and d =
−1.57 after alarm treatment. This was despite that the former
had already displayed small interindividual distance even before
the delivery of the alarm substance (SI Appendix, Fig. S9E).
Thus, taken together these results demonstrate elevated anxiety
and fear in sam2 KO fish.
Increase of mRNA Expression of Stress-Related crhb in sam2 KO Fish.
Aversive stimuli that induce fear and anxiety are expected to lead
to physiological changes: for example, neurohormonal stress
responses mediated by the hypothalamic–pituitary–adrenal (HPA)
axis (14, 44). A previous study demonstrated that disruption of
glucocorticoid-negative feedback of the HPA axis resulted in el-
evated cortisol levels and anxiety-like behavior in zebrafish (14).
We hypothesized that the increased level of anxiety in sam2 KO
Fig. 3. Increase of anxiety-related behaviors in sam2cnu1 KO zebrafish. (A–E) Novel tank tests of individually placed fish. The distance traveled (A) (sam2+/+,
n = 18; sam2−/−, n = 28; Cohen’s d = 0.24; Mann–Whitney U = 181, P = 0.11), average velocity (B) (sam2+/+, n = 18; sam2−/−, n = 28; Cohen’s d = 0.32; Mann–
Whitney U = 171, P = 0.07), and transition to upper half (C) (sam2+/+, n = 18; sam2−/−, n = 28; Cohen’s d = 0.19; Mann–Whitney U = 202, P = 0.27) were not
significantly changed in sam2 KO fish. However, the frequency of erratic behavior (D) (sam2+/+, n = 18; sam2−/−, n = 28; Cohen’s d = 1.65; Mann–Whitney U =
41, P < 0.00001) and the number of freezing fish (E) (sam2+/+, n = 18; sam2−/−, n = 27; Cohen’s d = 0.62; P = 0.042, Student’s t test) were increased in sam2 KO
fish. (F and G) Black/white preference (scototaxis) test. Distance traveled in white arena (F) (sam2+/+, n = 18; sam2−/−, n = 24; Cohen’s d = 1.06; Mann–Whitney
U = 85, P = 0.0032) and frequency of transitions (G) (sam2+/+, n = 18; sam2−/−, n = 24; Cohen’s d = 1.42; Mann–Whitney U = 61.5, P = 0.00016) were measured.
*P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant (P > 0.05).














fish may also be associated with dysregulation of the HPA axis.
Using in situ hybridization, we found sam2cnu1 KO fish to exhibit
elevated crhb expression, an important HPA axis marker, in the
PPa compared with wild-type (see, for example, Fig. 6 A–D). In-
creased crhb mRNA levels in the PPa, a region homologous to the
mammalian paraventricular nucleus (PVN), is consistent with
previous reports of dysregulated HPA axis function in zebrafish
and mice (14, 45).
Sam2 KO Mice also Exhibit Anxiety-Like and Fear-Related Behaviors.
To investigate whether the role of sam2 in anxiety and fear is
evolutionarily conserved or specific only to the zebrafish, we
generated a Sam2 KO mouse line (SI Appendix, Fig. S10) and
compared the behavior of these mutants to wild-type littermates.
Sam2 showed brain-specific expression in mouse similar to that
of zebrafish, having a higher expression level in the hippocampus
and Hb but not in the PVN (SI Appendix, Fig. S11). We found
Sam2 KO mice to spend significantly less time in the open arms
on an elevated plus maze (Fig. 5C) (Sam2+/+mice, 38.3 ± 9.16%,
n = 11; Sam2−/− mice, 19.66 ± 6.66%, n = 8) and to show in-
creased freezing in both the contextual (Fig. 5E) (Sam2+/+ mice,
42.86 ± 8.08%, n = 11; Sam2−/− mice, 69.74 ± 6.12%, n = 7) and
cued fear-conditioning tests (Fig. 5F) (Sam2+/+ mice, 40.33 ±
6.32%, n = 11; Sam2−/− mice, 70.95 ± 4.97%, n = 7) compared
with wild-type littermates. The elevated freezing in the null
mutant mice was not due to a motor function-related change, as
both mutant and wild-type animals exhibited similar levels of
freezing on training day (Fig. 5D) [two-way repeated-measures
ANOVA, Time × Group interaction: F(3, 48) = 0.48, P = 0.69,
Sam2+/+ mice, n = 11; Sam2−/− mice, n = 7]. Body weight (Fig.
5A) (Sam2+/+ mice, 24.86 ± 0.59 g, n = 25; Sam2−/− mice,
24.07 ± 0.39 g, n = 10) and total locomotion on an open-field test
(Fig. 5B) [two-way repeated-measures ANOVA, Time × Group
interaction: F(5, 75) = 0.32, P = 0.89, Sam2+/+ mice, n =11;
Sam2−/− mice, n = 6] were not significantly different between
Sam2 KO and wild-type control mice. Collectively, the Sam2 KO
mice exhibited phenotypical alterations reminiscent of the KO
zebrafish, suggesting that Sam2 plays a potentially critical and
evolutionally conserved role in regulating anxiety- and fear-
related behavioral responses.
Increase in the Frequency of Spontaneous Inhibitory Postsynaptic
Currents by SAM2. Increased activity in the stress axis is one of
the most enduring findings in both animal models and human
patients with anxiety. Elevated fear and anxiety responses in
mice are accompanied by both Crh mRNA overexpression and
increased excitability of the PVN neurons (14, 45). Similarly,
selective knockout of Crh in the PVN results in reduced anxiety
(46). Therefore, we hypothesized that Sam2 could regulate CRH
neuron excitability in the PVN. To investigate this hypothesis, we
exposed PVN CRH neurons to a 5-min-long bath application of
SAM2 (1 μM) (SI Appendix, Fig. S12). In response to this
treatment, we found a significant increase in the frequency of
spontaneous inhibitory postsynaptic currents (sIPSC); that is,
162.5 ± 39.76% of baseline (n = 11, P < 0.01, Wilcoxon signed-
rank matched-pairs test) (Fig. 6 F and G). We found no signif-
icant change in the sIPSC amplitude, however (100.9 ± 5.3% of
baseline, n = 11, P = 0.15, Wilcoxon signed-rank matched-pairs
Fig. 4. Anxiety-like behavior and increased social
cohesion in sam2cnu1 KO fish. Five fish (3-mo-old
male siblings) were placed as a group in a novel
tank. (A and A′) A snapshot of video tracking after
20-min novel tank test. (B and B′) Temporal 3D re-
constructions of video tracking before habituation
(early, 5–8 min, blue; Cohen’s d = −0.063) and after
habituation (late, 13–16 min, red; Cohen’s d = −0.80)
to the novel environment. (C and C′) Measurement
of social cohesion as the mean individual gap. We
measured the distance between the focal fish and
one of its shoal members (lines a, b, c, and d; in-
terindividual distances). P = 0.02 for control and P =
0.88 for sam2 KO fish (sam2+/+, n = 5; sam2−/−, n = 5).
*P < 0.05; ns, not significant (P > 0.05).
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test) (Fig. 6H). We also observed no significant differences in
evoked IPSC (eIPSC) amplitude and paired-pulse ratio (Fig. 6 I–
J, and K). Thus, we conclude that SAM2 is able to significantly
increase the frequency, but not the amplitude, of spontaneous
GABAergic currents onto CRH neurons, rather than the am-
plitude of evoked GABAergic currents. These observations in-
dicate that SAM2 may control tonic GABAergic inputs onto
CRH neurons.
Comparative Genomic Mapping Using Six CNVs at 12q14.1.Mutations
(i.e., microdeletions or duplications) arising at the 12q14.1 region
are characterized by a previously unreported feature set including
craniofacial anomalies, cryptorchidism, intellectual disability,
autism, and behavioral problems. Using six informative CNVs,
we were able to refine the candidate gene region encompassing
SAM2 at 12q14.1 (Fig. 7). We found deletions in two females,
GC42855 and GC48823, sized 6.2 Mb (chr12: 62,097,144 to
68,266,543/hg19) and 5.1 Mb (chr12: 58,011,515 to 63,115,073/
hg19), respectively (Fig. 7). GC48823 is 4-y-old with autism and
seizures, whereas GC42855 is 6-y-old with developmental delay.
A 1-Mb minimal overlapping region of these two deletions at
12q14.1 contains four genes including SAM2. Furthermore, we
identified two more small CNVs in the DECIPHER (database of
chromosomal imbalance and phenotype in humans using Ensembl
resources) human genome variants database (47) overlapping
the gene. Among them, patient 288660 with an 887-kb duplica-
tion (chr12: 61,271,591 to 62,158,216/hg19) has attention deficit
hyperactivity disorder, autism spectrum disorder, and general-
ized joint laxity. However, this duplication overlaps only the 3′
end of the gene and may not disrupt its function. More impor-
tantly, patient 290951 has inherited an 880-kb deletion (chr12:
62,038,772 to 62,918,916/hg19) encompassing SAM2 and USP15
in a three-generation pedigree from the maternal grandfather
through his mother with significant intellectual disability. Patient
290951 had a clinical diagnosis of autism spectrum disorder,
behavioral difficulties, and severe speech and language delay.
Overall he performed in the mild range of intellectual disability,
as did his mother and maternal grandfather, who all had the
same deletion. His unaffected brother, sister, and uncle did not
inherit the deletion (Fig. 7 B–D). In mice, Usp15 is ubiquitously
expressed in various tissues. Usp15 KO mice had normal survival
rate and did not show abnormalities in development, although its
deficiency enhanced T cell response against bacterial infection
and tumor (48). A 61-kb minimal overlapping region of these
four CNVs flanked by two blue vertical dotted lines encompasses
the 56-kb 3′ end of SAM2. These data suggest that SAM2 con-
tributes to the neurological phenotype of these patients. DE-
CIPHER also has two additional small CNVs in this region, not
including SAM2: child 251128 with behavioral problems, low-set
ears, intellectual disability, and speech delay, has inherited an
886-kb deletion (chr12: 62,799,199 to 63,684,842/hg19) from a
parent with similar phenotypes, and patient 287965 with a 224-kb
duplication (chr12: 61,544,595 to 61,768,510/hg19) has global
developmental delay.
Discussion
The functions of chemokines are well documented in the im-
mune system. However, the potential role of CNS-expressed
chemokines and chemokine-like proteins as neuromodulators is
still largely unknown. In this study, we identified a chemokine-
like sam gene family, showing CNS-specific expression. We
provide empirical evidence for the involvement of a chemokine-
like protein, SAM2, in vertebrate brain function and behavior
associated with the regulation of anxiety and fear responses.
The targeted knockout of a single gene, sam2, in zebrafish
produced an anxiogenic phenotype reminiscent of changes in-
duced by Hb ablation. For example, ablation of the dHb in
zebrafish has been shown to increase freezing and other behav-
ioral signs of anxiety (25, 49–51). The anxiety-like and fear-
related behavioral changes we detected in our zebrafish null
mutants were also observed in our mouse KO model, high-
lighting the evolutionarily conserved role of Sam2 in the regu-
lation of anxiety and fear in vertebrates.
Our in situ hybridization results showed the presence of sam2
transcripts in the telencephalic areas (Dm, Vd) and hypotha-
lamic regions of the zebrafish brain. The Dm and Vd are known
as the homologous regions for the mammalian amygdala and
striatum, respectively. The involvement of these regions in anx-
iety has been demonstrated by numerous behavioral and mo-
lecular studies using both mammalian species and zebrafish (25,
52). In addition to traditional measures of anxiety and fear—
such as freezing, thigmotaxis, or erratic movement—we also
found evidence of increased anxiety in our zebrafish null mutants
by measuring their shoaling responses. Shoaling is an adaptive
and natural antipredatory behavior utilized in the analysis and
modeling of vertebrate anxiety and fear (1). Furthermore, sam2
KO fish, when exposed to the alarm substance, exhibited
significantly increased shoaling (reduction of interindividual
Fig. 5. Increase of anxiety-related behaviors in Sam2
KO mice. (A) Sam2 KO mice have normal body
weight (Sam2+/+, n = 25; Sam2−/−, n = 10; Cohen’s
d = 0.31; unpaired two-tailed, Mann–Whitney U =
124, P = 0.98). (B) Sam2 KO mice show normal total
locomotion in an open-field test [Sam2+/+, n = 11;
Sam2−/−, n = 6; two-way repeated-measures ANOVA,
Time × Group interaction: F(5, 75) = 0.32, P = 0.89].
(C) Sam2 KO mice spent significantly less time in the
open arms on an elevated plus maze (Sam2+/+, n =
11; Sam2−/−, n = 8; Cohen’s d = 0.74; unpaired one-
tailed, Mann–Whitney U = 23, P = 0.045). (D) Sam2 KO
mice show similar levels of freezing response during
training days [Sam2+/+, n = 11; Sam2−/−, n = 7; two-way
repeated-measures ANOVA, Time × Group interaction:
F(3, 48) = 0.48, P = 0.69]. (E) Sam2 KOmice show higher
freezing behavior in contextual test 24 h after training
(Sam2+/+, n = 11; Sam2−/−, n = 7; Cohen’s d = 1.21;
unpaired two-tailed, Mann–Whitney U = 15, P = 0.035).
(F) Sam2 KO mice show higher freezing behavior in
cued test 24 h after training (Sam2+/+, n = 11; Sam2−/−,
n = 7; Cohen’s d = 1.75; unpaired two-tailed, Mann–
Whitney U = 7, P = 0.0028). *P < 0.05; **P < 0.01; ns,
not significant (P > 0.05).














distance) compared with wild-type. Also notably, novelty-
induced increase of shoaling remained persistently elevated in
the null mutants, whereas it showed the expected normal ha-
bituation (time-dependent reduction) in wild-type control fish
(Fig. 4). Consistent with these findings, our Sam2 KO mice also
exhibited increased anxiety-like responses, for example, on the
elevated plus maze (Fig. 5C).
In addition to the elevated anxiety-like and fear responses in
our null mutant zebrafish, we found an increase in crhb mRNA
expression in the hypothalamus. CRH neurons are under con-
stant GABAergic suppression in vivo (53), but importantly, our
experimental manipulation (i.e., bath application of SAM2) in-
creased sIPSC frequency. These data indicate that SAM2 plays a
role in tonic GABAergic suppression of CRH excitability, which
may, at least in part, be responsible for the elevated anxiety-like
responses observed in both KO models. It is also worth consid-
ering that the downstream effects of CRH and the resulting re-
lease of glucocorticoids may also contribute to the anxiety
phenotype (14, 54).
Identification of the specific neural circuits mediating the ef-
fects of SAM2 first requires the determination of neuronal cell
types or neurotransmitter systems involved. In case of gluco-
corticoid receptors, their actions on fear and anxiety behaviors
have recently been shown to be mediated via glutamatergic but
not GABAergic neural circuits in the mouse forebrain (45). We
performed in situ hybridization analysis with GABAergic, glu-
tamatergic, and sam2 markers in the adult fish brain to de-
termine colocalization. sam2 expression within the Vd, Vc, Hc,
and Hd was found to be predominantly confined to GAD65/67+
GABAergic neurons, whereas expression in the Dm revealed
colocalization with vglut2b+ glutamatergic neurons. Whether sam2-
expressing neurons employ GABA or glutamate as a second
transmitter remains to be determined (55). Also, whether sam2
regulates the neuronal activity of GABAergic or glutamatergic
neurons by neuromodulatory action will need to be ascertained in
the future. Nevertheless, the expression and colocalization patterns
reported in our current study open the possibility of a neuro-
modulatory role of sam2 in both excitatory and inhibitory neuro-
transmitter systems comprising anxiety circuitry.
The specific molecular mechanisms underlying increased
anxiety-like behavioral responses observed in sam2 KO fish will
require further characterization. Nevertheless, the behavioral
Fig. 6. Increase of mRNA expression of stress-related crhb in sam2cnu1 KO fish and spontaneous inhibitory postsynaptic currents onto CRH neurons by SAM2.
(A–D) Increase of crhbmRNA expression in sam2cnu1 KO fish (sam2+/+, n = 6; sam2−/−, n = 6). Ventral views of the whole brain of control sam2+/+ (A and C) and
sam2−/− KO fish (B and D). (A′ and B′) Higher magnifications of the boxed regions in A and B are the PPa in zebrafish, homologous to the mouse PVN. (Scale
bars, 200 μm.) (E) Representative photomicrograph of the Cre-dependent TdTomato in the PVN CRH neurons. (Magnification: E, 10×.) (F) Representative
voltage-clamp traces of sIPSCs in response to SAM2 application in PVN CRH neurons. (G) SAM2 application significantly increased sIPSC frequency. (H)
SAM2 did not affect sIPSC amplitude. (I) Representative voltage-clamp trace of eIPSC onto CRH neurons in response to SAM2 application. (J) SAM2 did not
affect the amplitude of eIPSCs. (K) SAM2 did not change the paired-pulse ratio. *P < 0.05; **P < 0.01.
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changes we found appeared to be unrelated to the serotonergic
neurotransmitter system, as the expression of indicative markers,
such as tphR and slc6a4a, were not affected by the loss of sam2
(SI Appendix, Fig. S6 P–Q′) (29, 56). However, after the novel
tank assays, sam2 KO fish did show higher level of c-fos ex-
pression in the entire brain compared with wild-type (SI Ap-
pendix, Fig. S6 S and S′), confirming their abnormal response to
novelty but also implying potential involvement of neurotrans-
mitters other than the glutamatergic and GABAergic systems.
Finally, comparative genomic mapping with microdeletions
and microduplications in human patients with intellectual dis-
ability, autism, and behavioral tantrums has identified SAM2 as a
candidate gene for these phenotypes in individuals with 12q14.1
CNVs (Fig. 7). Although the latter results do not prove the role
of SAM2 in these diseases, these results, together with our
findings with zebrafish and mice, present an interesting possi-
bility: evolutionarily distant species, such as fish, rodents, and
humans, may possess similar mechanisms underlying anxiety and
emotion, and these mechanisms may include sam2. We thus
propose that the discovery of the samdori gene family and the
functional information of one of its member sam2, may have
important translational relevance and therapeutic potential.
Materials and Methods
Full methods and any associated references are available in SI Appendix, SI
Materials and Methods.
Animals. All experimental protocols and procedures were approved and
conducted according to the approved guidelines and regulations of the
Animal Ethics Committee of Chungnam National University (CNU-00866).
Isolation of samdori Gene Family. We established a unique insertional mu-
tagenesis system based on the Sleeping Beauty transposon, called the golden
fish project (SI Appendix, Fig. S1). In addition to the GFP gene, we used a
melanin-concentrating hormone gene as a transgene reporter for visual
screening of mutants. During the course of mutagenesis, we mapped the
insertion site in a chemokine gene, named samdori (sam). The full-length
cDNAs of zebrafish sam-1a, 1b, 2, 3a, 3b, 4, 5a, and 5b genes were isolated
using the RACE technique. The sam2 KO zebrafish lines (sam2cnu1 and
sam2cnu2) and Sam2 KO mice were generated by the targeted mutagenesis
utilizing ZFNs (26, 27) and transcription activator-like endonucleases
(57), respectively.
Behavior Tests in Zebrafish and Mice. Male zebrafish siblings of identical age
(3-mo-old) and size were used for the following behavioral tests: open novel
tank (35, 36, 41), scototaxis (37), and shoaling behavior (1, 42). The open-
field test, elevated plus maze, and fear conditioning were employed in mice.
All values represent mean ± SEM.
Human Genetics Data. Patients GC42855 and GC48823 were identified among
a cohort of ∼32,700 patients undergoing clinical, oligonucleotide-based ar-
ray comparative genomic hybridization (aCGH) (58, 59) at Signature Geno-
mic Laboratories. The DECIPHER database is a publicly accessible web-based
resource of human genome variants with associated phenotypes, which fa-
cilitates the identification and interpretation of pathogenic genetic varia-
tion in thousands of patients with rare disorders worldwide (47). The
description of case 290951 was ascertained from the DECIPHER database.
Fig. 7. CNV mapping at 12q14.1 with six human patients, implicating SAM2 as a candidate gene. Deletions and duplications are depicted in red and blue,
respectively. (A) Alignment of three microdeletions and one microduplication at 12q14.1 has refined the candidate gene region to a 61 kb (arrows), which
contains 56-kb 3′ end of SAM2. Notably, the microdeletion in a 6-y-old boy 290951 with autism spectrum disorder and intellectual disability contains SAM2, as
well as USP15 and part of MON2. (B) Pedigree showing three family members affected by intellectual disability in three generations. We have confirmed the
deletion in each family member; II-2 (del/+), III-2 (del/+), III-3 (+/+), IV-1 (+/+), IV-2 (+/+), and IV-3 (del/+). (C) SAM2 copy number in the family as determined by
qPCR. The proband IV-3 has inherited the deletion from the maternal grandfather II-2 through his mother III-2 and affected members have only one SAM2
copy. The patient’s siblings are normal having two SAM2 copies. (D) Transcript levels of SAM2 in patient, his mother, sister, and white male control as revealed
by qRT-qPCR. SAM2 transcripts are reduced approximately by half in both the patient and his mother relative to control.














We tested the deletion in 290951 family members; II-2 (affected, has de-
letion), III-2 (mother, affected, has deletion), III-3 (uncle, unaffected, does
not have deletion), IV-1 (elder sister, unaffected, no deletion), IV-2 (elder
brother, unaffected, no deletion), IV-3 (the proband, affected, has the de-
letion). This study was approved by the Institutional Review Board of
Augusta University, Augusta, Georgia (HAC 0904264) for collection of
deidentified phenotypic and genotypic data of human subjects or, with in-
formed consent, for additional studies completed on blood or DNA. In-
formed consent, blood, and cells, were obtained from the family of 290951,
while deidentified data were used for the rest of the analyses.
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